Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
OGEN
OGEN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OGEN News
Oragenics Secures Clinical Trial Approval in Australia
10h ago
Newsfilter
Oragenics Advances ONP-002 Clinical Trials for Concussion Treatment
Feb 09 2026
Newsfilter
Oragenics Partners with DUCK FLATS Pharma to Advance Novel Concussion Therapy
Feb 03 2026
Newsfilter
Oragenics Engages with Global Clinical Research Leaders at SCOPE Summit
Feb 02 2026
Newsfilter
High Roller Technologies Inc Closes Direct Offering, Raises $25 Million
Jan 22 2026
Benzinga
Oragenics (OGEN) to Present Novel Therapy at Sequire Investor Summit 2026
Jan 14 2026
Newsfilter
Oragenics Q3 2025 Update for Shareholders
Nov 12 2025
Newsfilter
Oragenics Collaborates with Receptor.AI on Brain Health Product Line
Oct 08 2025
Yahoo Finance
Oragenics Q2 2025 Shareholder Update
Aug 11 2025
Newsfilter
Oragenics Partners With Sterling For U.S.-Based Manufacturing Of Concussion Drug ONP-002
Jul 16 2025
NASDAQ.COM
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development
Jul 16 2025
Newsfilter
Nasdaq Dips 150 Points; US ISM Manufacturing PMI Rises In June
Jul 01 2025
Benzinga
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
Jul 01 2025
TipRanks
US Stocks Mixed; Dow Gains Over 50 Points
Jul 01 2025
Benzinga
Why Is Oragenics Stock (OGEN) Down 55% Today?
Jul 01 2025
TipRanks
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Jul 01 2025
Benzinga
Show More News
